News Headline Summary

Medtronic (MDT) says the first patient is being treated in Medtronic clinical trial evaluating corevalue system in intermediate-risk patients

Reaction details (02:02)

- Medtronic shares unmoved by this latest news; trades USD 41.12 last (+0.6%).

17 Nov 2012 - 02:00 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: